222 related articles for article (PubMed ID: 28012493)
1. Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases.
Tsuji T; Tsuyuguchi K; Tachibana K; Kimura Y; Kobayashi T; Minomo S; Atagi S; Matsumura A; Hayashi S; Suzuki K
Respir Investig; 2017 Jan; 55(1):45-50. PubMed ID: 28012493
[TBL] [Abstract][Full Text] [Related]
2. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
3. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment for nontuberculous mycobacterial lung disease.
Kang YA; Koh WJ
Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
[TBL] [Abstract][Full Text] [Related]
5. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients.
Hirama T; Singer LG; Brode SK; Marras TK; Husain S
Transpl Infect Dis; 2021 Aug; 23(4):e13679. PubMed ID: 34184393
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacteria in patients with cystic fibrosis.
Leung JM; Olivier KN
Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
[TBL] [Abstract][Full Text] [Related]
8. Association of pulmonary nontuberculous mycobacteria with the outcomes of patients with lung cancer: A retrospective matched cohort study with a special emphasis on the impact of chemotherapy.
Liao TY; Wang JY; Shih JY
J Microbiol Immunol Infect; 2023 Apr; 56(2):392-399. PubMed ID: 36456443
[TBL] [Abstract][Full Text] [Related]
9. Microbiome Diversity in Sputum of Nontuberculous Mycobacteria Infected Women with a History of Breast Cancer.
Philley JV; Kannan A; Olusola P; McGaha P; Singh KP; Samten B; Griffith DE; Dasgupta S
Cell Physiol Biochem; 2019; 52(2):263-279. PubMed ID: 30816674
[TBL] [Abstract][Full Text] [Related]
10. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
Kwon YS; Koh WJ
J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
[TBL] [Abstract][Full Text] [Related]
12. Underlying host risk factors for nontuberculous mycobacterial lung disease.
Chan ED; Iseman MD
Semin Respir Crit Care Med; 2013 Feb; 34(1):110-23. PubMed ID: 23460011
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity.
Provoost J; Valour F; Gamondes D; Roux S; Freymond N; Perrot E; Souquet PJ; Kiakouama-Maleka L; Chidiac C; Lina G; Dumitrescu O; Sénéchal A; Ader F
BMC Infect Dis; 2018 Dec; 18(1):659. PubMed ID: 30547753
[TBL] [Abstract][Full Text] [Related]
14. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
Sawka A; Burke A
Clin Chest Med; 2023 Dec; 44(4):815-828. PubMed ID: 37890918
[TBL] [Abstract][Full Text] [Related]
15. [Study on pulmonary lesions in which nontuberculous mycobacteria were detected by percutaneous aspiration--a proposal to add "culture positivity of percutaneous aspiration material" to the bacteriological diagnostic criteria of pulmonary nontuberculous mycobacterial diseases].
Nakahara Y; Mochizuki Y; Kawamura T; Sasaki S; Morimoto A; Mizumori Y; Tsukamoto H; Watanabe E; Yokoyama T
Kekkaku; 2013 Mar; 88(3):283-9. PubMed ID: 23672168
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.
Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M
Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951
[TBL] [Abstract][Full Text] [Related]
17. Medications and monitoring in nontuberculous mycobacteria infections.
Egelund EF; Fennelly KP; Peloquin CA
Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
[TBL] [Abstract][Full Text] [Related]
18. Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study.
Blanc P; Dutronc H; Peuchant O; Dauchy FA; Cazanave C; Neau D; Wirth G; Pellegrin JL; Morlat P; Mercié P; Tunon-de-Lara JM; Doutre MS; Pélissier P; Dupon M
PLoS One; 2016; 11(12):e0168290. PubMed ID: 27959960
[TBL] [Abstract][Full Text] [Related]
19. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials.
Aksamit TR; Philley JV; Griffith DE
Respir Med; 2014 Mar; 108(3):417-25. PubMed ID: 24484653
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients.
Koh WJ; Kwon OJ; Lee KS
Korean J Radiol; 2002; 3(3):145-57. PubMed ID: 12271159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
